Jonathan Bornstein, President of Amprius Lab at Amprius Technologies, Inc. (AMPX), sold 300,000 shares at $4.02 ($1.2M) on 2023-12-06, disclosed to the SEC on 2023-12-07.
Scheduled sale ($1.2M) by President of Amprius Lab under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.28 | 47,756 | $204K | 16.8% |
| 2 | $4.28 | 47,756 | $204K | 16.8% |
| 3 | $4.02 | 47,767 | $192K | 15.8% |
| 4 | $4.02 | 47,767 | $192K | 15.8% |
| 5 | $3.88 | 54,477 | $211K | 17.4% |
| 6 | $3.88 | 54,477 |
| $211K |
| 17.4% |
| Total | $4.05 avg | 300,000 | $1.2M | 100% |
| Filing → |
| AMPX | SELL | 2024-08-22 | $19K | — | Filing → |
| AMPX | SELL | 2024-05-24 | $27K | — | Filing → |
| AMPX | SELL | 2024-04-03 | $600K | — | Filing → |